fluorescein-5-isothiocyanate has been researched along with Breast Neoplasms in 92 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (20.65) | 18.7374 |
| 1990's | 15 (16.30) | 18.2507 |
| 2000's | 29 (31.52) | 29.6817 |
| 2010's | 19 (20.65) | 24.3611 |
| 2020's | 10 (10.87) | 2.80 |
| Authors | Studies |
|---|---|
| Behera, C; Behl, A; Chhillar, AK; Datta, TK; Gupta, PN; Kumar, S; Mintoo, MJ; Sarwalia, P | 1 |
| Almeida, CP; Andrade, LO; Borges, IT; Cassali, GD; Del Puerto, HL; Eliezeck, M; Ferreira, E; Gomes, HW; Guatimosim, S; Martins, AS; Oliveira, CA; Rezende, L; Ribeiro, TS; Rodrigues, RC; Silva, FHS; Souza-Fagundes, EM; Underwood, A | 1 |
| Abdelazim, IA; Aitmagambetova, M; Amanzholkyzy, A; Donayeva, A; Gubasheva, G; Imanbaev, N; Kandygulova, G; Kereyeva, N; Khamidullina, Z; Koishybaev, A; Sakhanova, S; Saparbayev, S; Smagulova, G; Tulyaeva, A; Zholmukhamedova, D | 1 |
| Chang, L; Chen, X; Gao, X; Li, Q; Li, Y; Luo, H; Wei, X; Westover, KD; Zhang, Y; Zhou, Z; Zhu, J | 1 |
| Bravo, MG; James, TA; Johnson, AR; Lee, BT; Singhal, D; Suami, H | 1 |
| Nankali, E; Shaabanzadeh, M; Torbati, MB | 1 |
| Bidkar, A; Ghosh, SS; Islam, T; Majumder, M; Mukherjee, AK; Mukhopadhyay, R; Utkin, Y | 1 |
| Abdelhady, HG; Al Khalil, N; Aldarwesh, A; Aleanizy, FS; Aleshaiwi, L; Alghamdi, M; Alkahtani, H; Alqahtani, FY; Alqahtani, QH; Alquadeib, B; Alsarra, I; Seto, S | 1 |
| Belloli, S; Colombo, M; De Palma, A; Mauri, P; Mazza, D; Moresco, RM; Prosperi, D; Rainone, P; Rigamonti, V; Ripamonti, M; Roffia, V; Salvioni, L; Spinelli, AE; Sudati, F | 1 |
| Cao, YJ; Choi, SH; Kazane, SA; Li, S; Liu, Z; Wang, X; Wang, Z; Wei, X; Yun, H; Zhang, Z; Zhao, L | 1 |
| Bhutto, DF; Bolli, R; Centner, CC; Kopechek, JA; Moore Iv, JB; Murphy, EM; Priddy, MC | 1 |
| Kanomata, N; Kurebayashi, J; Moriya, T | 1 |
| Barshack, I; Benayoun, L; Clementi, C; Eldar-Boock, A; Miller, K; Pasut, G; Polyak, D; Satchi-Fainaro, R; Shaked, Y | 1 |
| Bhagat, AA; Chaudhuri, PK; Chen, PC; Guan, G; Han, J; Lee, SC; Lee, WC; Lim, CT; Lim, WT; Luan, KB; Tan, DS; Warkiani, ME | 1 |
| Liu, T; Liu, X; Qian, J; Suo, A; Wang, H; Xu, M; Xu, W; Yao, Y | 1 |
| Ari, K; Ichedef, C; Kilcar, AY; Medine, EI; Teksoz, S; Ucar, E; Yilmaz, B | 1 |
| Bosse, T; Burggraaf, J; Cohen, AF; de Kroon, CD; Gaarenstroom, KN; Hoogstins, CE; Low, PS; Smit, VT; Tummers, QR; Vahrmeijer, AL; van de Velde, CJ; van Poelgeest, MI; Vuyk, J | 1 |
| Adams, DJ; Bansal, V; Kulhari, H; Kuncha, M; Naidu, VGM; Pooja, D; Shrivastava, S; Sistla, R | 1 |
| Abou-Aisha, K; Abozeid, SM; Hathout, RM | 1 |
| Benech, JC; Cabral, P; Cerecetto, H; Fernández, M; Lecot, N; Oddone, N; Rodriguez-Haralambides, A | 1 |
| Chen, D; Guan, G; Hu, H; Liu, D; Qiao, M; Sun, Y; Zhang, J; Zhang, M; Zhang, X; Zhao, X | 1 |
| Artemov, D; Bhujwalla, ZM; Kato, Y; Mikhaylova, M; Stasinopoulos, I | 1 |
| Medarova, Z; Moore, A; Pantazopoulos, P; Rashkovetsky, L | 1 |
| Koshima, I; Nakasato, M; Shibue, T; Suzuki, S; Taniguchi, T | 1 |
| Aung, HH; Li, XL; McEntee, E; Sun, S; Tong, R; Wang, CZ; Xie, JT; Yuan, CS | 1 |
| Ahmad, W; Ballal, R; Cheema, A; Rosen, EM; Saha, T | 1 |
| Fang, C; Gao, J; Guo, Y; Hou, S; Kou, G; Li, B; Li, H; Qian, W; Shi, S; Wang, C; Wang, H; Wei, H; Zhang, D; Zhang, X; Zhao, L | 1 |
| Gust, R; Krüger, M; Richter, J; Scutaru, AM; Wenzel, M | 1 |
| Arns, S; Donohue, E; Roberge, M; Sternberg, E; Tovey, A; Vogl, AW; Young, RN | 1 |
| Hahn, SK; Jung, H; Kim, K; Lee, DW; Oh, EJ; Park, K; Park, KM; Ryu, SH; Yang, JA | 1 |
| Cho, SH; Hwang, SY; Lee, BH; Lee, EK; Song, YJ | 1 |
| Lee, KJ; Lee, SJ; Park, HY; Yoon, MY | 1 |
| Aher, ND; Banerjee, SS; Bhansali, SG; Jalota-Badhwar, A; Khandare, JJ; Kharas, F; Satavalekar, SD | 1 |
| Ingber, DE; Kanapathipillai, M; Kang, JH; Krause, S; Mammoto, A; Tobin, H | 1 |
| Cao, H; Chen, T; Dang, W; Li, B; Tang, H; Tian, W; Wang, L; Wang, X; Zhang, X | 1 |
| Han, KT; Kim, SP; Lee, GS; Namkoong, SE; Rha, JG; Ryu, KS | 1 |
| Ehemann, V; Schwab, M; Zitzmann, S | 1 |
| Lehmann, L; Metzler, M; Schmitt, E; Stopper, H | 1 |
| Fishel, ML; Kelley, MR; Seo, YR; Smith, ML | 1 |
| Albanell, J; Anido, J; Arribas, J; Averbuch, S; Baselga, J; Guzmán, M; Matar, P; Rojo, F | 1 |
| Ciobotaro, P; Drucker, L; Lishner, M; Neumann, A; Radnay, J; Shapira, J; Shapiro, H | 1 |
| Bizon, R; Borojevic, R; Machado, JJ; Magalhães, MM; Nicola, MH; Nobre, JS; Rodarte, RS; Sollero, T; Takiya, CM | 1 |
| Colledge, WH; Scott, ES; Shaw, PA; Wiseman, JW | 1 |
| Da Poian, AT; de Freitas, MS; Holandino, C; Marinho-Carvalho, MM; Meira, DD; Sola-Penna, M; Teixeira, CA; Veiga, VF | 1 |
| Bojenko, VK; Bovin, NV; Pazynina, GV; Rapoport, EM; Sapot'ko, YB | 1 |
| Baumrucker, CR; Green, MH; Schanbacher, F; Shang, Y | 1 |
| Emlet, D; Pollice, A; Shackney, SE; Smith, CA | 1 |
| Chen, HW; Louie, MC; Revenko, AS; Yao, J; Zou, JX | 1 |
| Müller, J; Nieber, M; Robitzki, AA; Rothermel, A; Schmidt, M; Wolf, P | 1 |
| Bossen, C; Canarelli, S; Fisch, I; Freitag, R; Motmans, K; Raus, J; Vandevyver, C | 1 |
| Das, T; Jiang, WG; Mansel, RE; Martin, TA | 1 |
| Bonfrer, H; Boogerd, W; Dekker, L; Heeren, R; Jenster, G; Luider, TM; Römpp, A; Smitt, PS; Spengler, B; Taban, I | 1 |
| Bae, YH; Lee, ES; Mohajer, G | 1 |
| Chen, D; Chen, Q; Jiang, C; Wang, C | 1 |
| Choi, Bt; Choi, Yh; Kim, GY; Lee, Wh; Moon, DO; Park, C; Ryu, CH | 1 |
| Amano, K; Ezaki, H; Nishiki, M; Okumichi, T; Yamane, M | 1 |
| Ariens, AT; Labruyère, W; Lindeman, J; van Marle, J; van Weeren-Kramer, J | 1 |
| Baak, JP; Boon, ME; Lindeman, J; Meijer, CJ; Persijn, JP; van Marle, J; van Niewenhuizen, W | 1 |
| O'Connell, MD; Said, JW | 1 |
| Failly-Crepin, C; Geuskens, M; Pineiro, A; Uriel, J; Villacampa, MJ | 1 |
| Walker, RA | 1 |
| Chong, KC; Furnival, CM; Visona, A; Watson, LR | 1 |
| Cheng, ZM; Louis, CJ; Sztynda, T; Wyllie, RG | 1 |
| Budwit, DA; Cox, EB; Georgiade, G; Hiatt, KB; Leight, G; McCarty, KS; Reintgen, D; Siegler, HF | 1 |
| Louis, CJ; Wyllie, RG | 1 |
| Nordenskjöld, B; Stål, O; Wingren, S | 1 |
| Clevenger, CV; Jardines, L; Khandewal, M; Stadtmauer, E | 1 |
| Mukthar, D; Schenker, T; Schumacher, U | 1 |
| Graeff, H; Harbeck, N; Höfler, H; Schmitt, M; Schüren, E; Yamamoto, N | 1 |
| Eppenberger, U; Kueng, W; Liu, R; Loop, P; Mueller, H; Wosikowski, K | 1 |
| Block, NL; Ciancio, G; Pollack, A | 1 |
| Bolton, WE; Gupta, RK; Lee, SY; O'Brien, MC | 1 |
| Gasic, MJ; Kljajic, Z; Opric, MM; Perunovic, B; Poznanovic, S; Pupic, G; Sladic, D | 1 |
| Chew, K; DeVries, S; Goodson, WH; Ljung, BM; Nishizaki, T; Thor, A; Waldman, FM | 1 |
| Fusek, M; Hilgert, I; Vetvicka, V; Vetvickova, J; Voburka, Z | 1 |
| Chiu, SC; Harn, HJ; Ho, LI; Lee, WH; Shen, KL; Yu, JC; Yueh, KC | 1 |
| Ogawa, Y; Onishi, S; Saibara, T | 1 |
| Baldetorp, B; Johansson, MC; Oredsson, SM | 1 |
| Bowden, ET; Coopman, PJ; Mueller, SC | 1 |
| Brown, K; Farkas, DL; Pollice, AA; Shackney, SE; Silverman, JF; Smith, CA | 1 |
| Hillemanns, P; Kapsner, T; Kimmig, R; Wimberger, P | 1 |
| Andersson, LC; Krogerus, L | 1 |
| Baba, N; Hattori, T; Kegoya, Y; Kuninobu, H; Takayama, T; Toge, T; Yamaguchi, Y | 1 |
| Behnken, LJ; Heicke, B; Hienz, HA; Hildebrand, U; Klein, PJ; Remmele, W; Scheidt, E; Vierbuchen, M | 1 |
| Böck, G; Dapunt, O; Daxenbichler, G; Dürken, M; Marth, C | 1 |
| Furue, M; Hino, H; Ohara, K; Tamaki, K | 1 |
| De Potter, CR; Eechaute, W; Leusen, I; Roels, H | 1 |
| Berthois, Y; Gandilhon, P; Martin, PM; Mittre, H; Pourreau-Schneider, N; Tubiana, N | 1 |
| Bezwoda, WR; Dansey, R; Murray, J; Ninin, D | 1 |
| Ashcroft, RG | 1 |
| Gunduz, N | 1 |
| Benz, C; Lee, SH; Wiznitzer, I | 1 |
1 trial(s) available for fluorescein-5-isothiocyanate and Breast Neoplasms
| Article | Year |
|---|---|
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Topics: Administration, Intravenous; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; False Positive Reactions; Feasibility Studies; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folate Receptor 1; Folic Acid; Humans; Intraoperative Care; Luminescent Measurements; Middle Aged; Netherlands; Optical Imaging; Ovarian Neoplasms; Predictive Value of Tests; Reproducibility of Results | 2016 |
91 other study(ies) available for fluorescein-5-isothiocyanate and Breast Neoplasms
| Article | Year |
|---|---|
Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
Topics: Animals; Annexin A5; Breast Neoplasms; Cell Line, Tumor; Deoxycytidine; Female; Fluorescein-5-isothiocyanate; Gemcitabine; Humans; Mice; Mucin-1; Nanoparticles; Polyesters; Polyethylene Glycols | 2022 |
Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer.
Topics: bcl-2-Associated X Protein; Breast Neoplasms; Carcinoma, Ductal, Breast; Caspase 3; Female; Fluorescein-5-isothiocyanate; Humans; RNA, Messenger; SOXB1 Transcription Factors; Tumor Suppressor Proteins; Up-Regulation | 2022 |
The γ-H2AX foci as an indicator for double-stranded DNA breaks and response to ongoing chemotherapy in breast cancer women: a pilot study.
Topics: Breast Neoplasms; DNA Breaks, Double-Stranded; DNA Damage; Female; Fluorescein-5-isothiocyanate; Histones; Humans; Pilot Projects | 2023 |
Dynamic ultrasound molecular-targeted imaging of senescence in evaluation of lapatinib resistance in HER2-positive breast cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fluorescein-5-isothiocyanate; Humans; Lapatinib; Receptor, ErbB-2; Ultrasonography | 2023 |
The All but Forgotten Mascagni-Sappey Pathway: Learning from Immediate Lymphatic Reconstruction.
Topics: Adult; Aged; Anastomosis, Surgical; Axilla; Axillary Vein; Breast Cancer Lymphedema; Breast Neoplasms; Coloring Agents; Databases, Factual; Female; Fluorescein-5-isothiocyanate; Humans; Lymph Node Excision; Lymphatic Vessels; Microsurgery; Middle Aged; Plastic Surgery Procedures; Retrospective Studies; Rosaniline Dyes; Upper Extremity | 2020 |
Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imaging.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Drug Stability; Female; Fluorescein-5-isothiocyanate; Folic Acid; Humans; Inhibitory Concentration 50; MCF-7 Cells; Nanocapsules; Solubility; Tamoxifen | 2020 |
Nerve growth factor from Indian Russell's viper venom (RVV-NGFa) shows high affinity binding to TrkA receptor expressed in breast cancer cells: Application of fluorescence labeled RVV-NGFa in the clinical diagnosis of breast cancer.
Topics: Animals; Breast Neoplasms; Female; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; MCF-7 Cells; Nanoparticles; Neoplasm Proteins; Nerve Growth Factor; Optical Imaging; PC12 Cells; Rats; Receptor, trkA; Staining and Labeling; Viper Venoms | 2020 |
Trastuzumab Targeted Neratinib Loaded Poly-Amidoamine Dendrimer Nanocapsules for Breast Cancer Therapy.
Topics: Breast Neoplasms; Cell Line, Tumor; Dendrimers; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Fluorescein-5-isothiocyanate; Humans; Molecular Targeted Therapy; Nanocapsules; Nylons; Polyamines; Quinolines; Receptor, ErbB-2; Trastuzumab | 2020 |
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Drug Carriers; Endocytosis; Female; Fluorescein-5-isothiocyanate; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyethylene Glycols; Proteome; Proteomics; Radiopharmaceuticals; Receptor, ErbB-2; Silicon Dioxide; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2021 |
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers.
Topics: Amino Acids; Antibodies, Bispecific; Antigenic Drift and Shift; Antigens, Neoplasm; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescein-5-isothiocyanate; Humans; Immunoconjugates; Immunotherapy, Adoptive; Molecular Targeted Therapy; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Chimeric Antigen; T-Lymphocytes | 2021 |
Effect of Molecular Weight on Sonoporation-Mediated Uptake in Human Cells.
Topics: Breast Neoplasms; Cell Membrane Permeability; Cells, Cultured; Dextrans; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mesoderm; Microbubbles; Molecular Weight; Myocardium; Sonication | 2018 |
Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.
Topics: Adult; Antineoplastic Agents, Immunological; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorescein-5-isothiocyanate; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Phosphorylation; Prognosis; Receptor, ErbB-2; Receptor, ErbB-3; Retrospective Studies; Trastuzumab | 2019 |
Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Topics: Alendronate; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fluorescein-5-isothiocyanate; Human Umbilical Vein Endothelial Cells; Humans; Mice; Micelles; Neovascularization, Physiologic; Paclitaxel; Polyethylene Glycols; Tibia; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells.
Topics: Antibodies, Immobilized; Breast Neoplasms; Cell Line, Tumor; Cell Separation; Cell Survival; Female; Fluorescein-5-isothiocyanate; Humans; Keratins; Leukocyte Common Antigens; Lung Neoplasms; Microfluidic Analytical Techniques; Microscopy, Confocal; Neoplastic Cells, Circulating; Receptor, ErbB-2 | 2014 |
Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
Topics: Annexin A5; Apoptosis; Breast Neoplasms; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Electrophoresis, Agar Gel; Endocytosis; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Folic Acid; Humans; Hydrodynamics; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Micelles; Nanoparticles; Particle Size; Polymers; Proto-Oncogene Proteins c-bcl-2; Proton Magnetic Resonance Spectroscopy; RNA, Small Interfering; Static Electricity | 2015 |
In Vitro/In Vivo Evaluation of Radiolabeled [(99m)Tc(CO)3](+)-Hydroxyurea and Fluorescein Isothiocyanate-Hydroxyurea.
Topics: Animals; Breast Neoplasms; Dextrans; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Hydroxyurea; In Vitro Techniques; Male; Optical Imaging; Organotechnetium Compounds; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tumor Cells, Cultured | 2016 |
Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer.
Topics: Animals; Biocompatible Materials; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dendrimers; Female; Fluorescein-5-isothiocyanate; Humans; Mice; Molecular Targeted Therapy; Receptor, ErbB-2; Trastuzumab | 2016 |
Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
Topics: Animals; Breast Neoplasms; Cations; Cell Adhesion Molecules; Cell Death; Endocytosis; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein-5-isothiocyanate; Fluorescence; Gelatin; Gene Silencing; Glutaral; Humans; MCF-7 Cells; Membrane Proteins; Nanoparticles; Neoplasm Metastasis; Particle Size; RNA-Binding Proteins; RNA, Small Interfering; Sus scrofa; Transfection; Trimethyl Ammonium Compounds | 2016 |
In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Dendrimers; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Mice; Mice, Inbred BALB C; Nylons | 2016 |
The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Dendrimers; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Exocytosis; Female; Fluorescein-5-isothiocyanate; Humans; MCF-7 Cells; Multidrug Resistance-Associated Proteins; Nylons | 2016 |
Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cations; Cell Line, Tumor; Contrast Media; Cyclooxygenase 2; Dextrans; Down-Regulation; Drug Delivery Systems; Female; Ferrosoferric Oxide; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gadolinium DTPA; Humans; Injections, Intravenous; Iron; Liposomes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, SCID; Neoplasm Proteins; Organometallic Compounds; Oxides; Polyethylene Glycols; RNA, Small Interfering; Transfection; Transplantation, Heterologous | 2009 |
Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Environmental Monitoring; Female; Fluorescein-5-isothiocyanate; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Mucin-1; Peptides; Treatment Outcome | 2009 |
Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cells.
Topics: Adenoviridae; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Genetic Therapy; Glutathione Transferase; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Models, Biological; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Xenograft Model Antitumor Assays | 2009 |
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Lung Neoplasms; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Tumor Cells, Cultured | 2009 |
Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Deoxyguanosine; DNA Glycosylases; DNA Repair; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Genes, BRCA1; Humans; Isotope Labeling; Neoplasm Proteins; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Oligonucleotide Probes; Radioisotopes; Recombinant Fusion Proteins; Substrate Specificity; Transfection; Ubiquitin-Protein Ligases | 2009 |
Development and characterization of a fully functional small anti-HER2 antibody.
Topics: Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Antigens; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fluorescein-5-isothiocyanate; Humans; Molecular Biology; Molecular Mimicry; Receptor, ErbB-2; Receptors, Fc; Trastuzumab | 2009 |
Investigations on the use of fluorescence dyes for labeling dendrimers: cytotoxicity, accumulation kinetics, and intracellular distribution.
Topics: Adenocarcinoma; Benzene Derivatives; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dansyl Compounds; Dendrimers; Drug Delivery Systems; Endosomes; Female; Fluorescein-5-isothiocyanate; Fluorescence; Fluorescent Dyes; Humans; Kinetics; Microscopy, Confocal; Naphthalimides | 2010 |
Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin.
Topics: Antineoplastic Agents; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dextrans; Drug Design; Female; Fluorescein-5-isothiocyanate; Green Fluorescent Proteins; Humans; Microscopy, Electron; Phagosomes; Porphyrins; Verteporfin | 2011 |
Theranostic systems assembled in situ on demand by host-guest chemistry.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Bridged-Ring Compounds; Cell Line, Tumor; Female; Fluorescein-5-isothiocyanate; Humans; Hyaluronic Acid; Imidazoles; Male; Rats; Rats, Sprague-Dawley; Receptors, Formyl Peptide; Receptors, Lipoxin; Spermidine | 2011 |
Cellular imaging assay for early evaluation of an apoptosis inducer.
Topics: Annexin A5; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cytological Techniques; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Microscopy, Confocal; Phosphatidylserines; Staurosporine; Surface Plasmon Resonance; Tetrazolium Salts; Thiazoles | 2011 |
Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.
Topics: Amino Acid Sequence; Bacteriophage M13; Biomarkers, Tumor; Breast Neoplasms; Epitopes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Hyaluronan Receptors; Molecular Sequence Data; Neoplastic Stem Cells; Peptide Library; Peptides; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins | 2012 |
PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Diagnostic Imaging; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Magnetite Nanoparticles; Microscopy, Electron, Transmission; Nanoconjugates; Nanotechnology; Nanotubes, Carbon; Optical Phenomena; Polyethylene Glycols | 2012 |
A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
Topics: Animals; Antibodies, Immobilized; Antigens, Polyomavirus Transforming; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Disease Models, Animal; Female; Fluorescein-5-isothiocyanate; Humans; Immunomagnetic Separation; Mice; Mice, Transgenic; Microfluidic Analytical Techniques; Neoplasm Metastasis; Neoplastic Cells, Circulating; Plasmids; Simian virus 40 | 2012 |
Suppression of tumor invasion and migration in breast cancer cells following delivery of siRNA against Stat3 with the antimicrobial peptide PR39.
Topics: Amino Acid Sequence; Animals; Antimicrobial Cationic Peptides; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fluorescein-5-isothiocyanate; Gene Silencing; Gene Transfer Techniques; Mice; Molecular Sequence Data; RNA, Small Interfering; STAT3 Transcription Factor | 2012 |
Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7).
Topics: Breast Neoplasms; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Phycoerythrin; Propidium; Staining and Labeling; Tumor Cells, Cultured | 2002 |
Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo.
Topics: Animals; Breast Neoplasms; Endothelium, Vascular; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Protein Binding; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Hormonal and genotoxic activity of resveratrol.
Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Fluorescein-5-isothiocyanate; Humans; Kinetochores; Lymphoma; Metaphase; Mice; Micronucleus Tests; Molecular Structure; Protein Binding; Receptors, Estrogen; Resveratrol; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured | 2002 |
Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.
Topics: Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cell Survival; DNA Glycosylases; DNA Repair; DNA, Mitochondrial; Fluorescein-5-isothiocyanate; Genetic Therapy; Humans; Methyl Methanesulfonate; Microscopy, Confocal; Mitochondria; N-Glycosyl Hydrolases; Staining and Labeling; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2003 |
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Dimerization; Dose-Response Relationship, Drug; ErbB Receptors; Flow Cytometry; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Ligands; Models, Biological; Neuregulin-1; Phosphorylation; Precipitin Tests; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Time Factors | 2003 |
The effects of doxorubicin on apoptosis and adhesion molecules of normal peripheral blood leukocytes-an ex vivo study.
Topics: Adult; Aged; Annexin A5; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Adhesion Molecules; Cell Membrane; Doxorubicin; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; In Vitro Techniques; Leukocytes; Middle Aged; Neutrophils; Treatment Outcome | 2003 |
Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata.
Topics: Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Carcinoma; Cell Adhesion; Cell Division; Cell Line; Coculture Techniques; DNA, Complementary; Fluorescein-5-isothiocyanate; Hepatocyte Growth Factor; Humans; Keratins; Neoplasm Metastasis; Protein Binding; Proto-Oncogene Proteins c-met; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tumor Cells, Cultured | 2003 |
Enhancement of gene delivery to human airway epithelial cells in vitro using a peptide from the polyoma virus protein VP1.
Topics: Animals; Breast Neoplasms; Bronchi; Capsid Proteins; Cell Adhesion; Cell Polarity; Cells, Cultured; Electrophoresis, Agar Gel; Epithelial Cells; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Humans; Luciferases; Mice; Mice, Inbred BALB C; Mutation; Peptides; Transfection; Tumor Cells, Cultured | 2005 |
Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.
Topics: Actins; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Clotrimazole; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fructose-Bisphosphate Aldolase; Glucose; Growth Inhibitors; Humans; Lactic Acid; Phalloidine; Phosphofructokinase-1; Rhodamines; Streptavidin | 2005 |
Sialoside-binding macrophage lectins in phagocytosis of apoptotic bodies.
Topics: Acrylic Resins; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Glycoconjugates; Humans; Lectins; Macrophages; Membrane Glycoproteins; Phagocytosis; Receptors, Immunologic; Sialic Acid Binding Ig-like Lectin 1; Sialic Acids | 2005 |
Lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Cattle; Cell Cycle; Cell Division; Cell Line, Tumor; Cells, Cultured; Drug Interactions; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ki-67 Antigen; Lactoferrin; Mammary Glands, Animal; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Retinoids; Signal Transduction; Transfection; Tretinoin | 2006 |
A simple correction for cell autofluorescence for multiparameter cell-based analysis of human solid tumors.
Topics: Breast Neoplasms; Cell Line, Tumor; Computer Simulation; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Laser Scanning Cytometry; Lung Neoplasms; Receptor, ErbB-2 | 2006 |
Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity.
Topics: Acetyltransferases; Adenoviridae; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Diploidy; Female; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, cdc; Genes, Reporter; Glioblastoma; Green Fluorescent Proteins; HeLa Cells; Histone Acetyltransferases; Humans; Indoles; Luciferases; Microscopy, Fluorescence; Nuclear Receptor Coactivator 3; Oncogene Proteins; Promoter Regions, Genetic; Proto-Oncogene Mas; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Trans-Activators; Tumor Stem Cell Assay | 2006 |
Real-time measurement of PMA-induced cellular alterations by microelectrode array-based impedance spectroscopy.
Topics: Alloys; Breast Neoplasms; Cell Line, Tumor; Electric Impedance; Epithelium; Feasibility Studies; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunohistochemistry; Microelectrodes; Microscopy, Fluorescence; Nanotechnology; Nickel; Oligonucleotide Array Sequence Analysis; Spectrum Analysis; Tetradecanoylphorbol Acetate; Titanium | 2006 |
Investigation and molecular mimicry of the antigen involved in the interaction between the monoclonal antibody 5D10 and the human breast cancer cell line MCF-7.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Chromatography, Gel; DNA, Viral; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Humans; Molecular Mimicry; Oligopeptides; Peptide Library; Sequence Analysis, DNA | 2007 |
Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid.
Topics: Antioxidants; Breast Neoplasms; Cell Culture Techniques; Cell Line; Cell Line, Tumor; Cell Membrane Permeability; Cell Movement; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epithelial Cells; Estradiol; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; gamma-Linolenic Acid; Humans; Membrane Proteins; Occludin; Phosphoproteins; Selenium; Tight Junctions; Zonula Occludens-1 Protein | 2007 |
Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS.
Topics: Breast Neoplasms; Chromatography, Liquid; Cyclotrons; Female; Fluorescein-5-isothiocyanate; Humans; Meningeal Neoplasms; Nanotechnology; Neoplasm Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2007 |
Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Micelles; Polymers | 2007 |
Exogenous PTEN gene induces apoptosis in breast carcinoma cell line MDA468.
Topics: Apoptosis; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Epidermal Growth Factor; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genetic Therapy; Humans; Phosphorylation; Plasmids; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Recombinant Proteins; Reference Standards; RNA, Messenger; Transfection | 2007 |
Beta-sitosterol sensitizes MDA-MB-231 cells to TRAIL-induced apoptosis.
Topics: Annexin A5; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Formazans; Humans; Hypolipidemic Agents; Sitosterols; Tetrazolium Salts; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Estrogen receptors in human breast cancer detected by the fluorescent estradiol histochemical and dextran coated charcoal techniques.
Topics: Breast Neoplasms; Charcoal; Dextrans; Double-Blind Method; Estradiol; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Receptors, Estrogen; Thiocyanates | 1984 |
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothiocyanate; Fluoresceins; Frozen Sections; Histocytochemistry; Humans; Nafoxidine; Receptors, Estrogen; Serum Albumin, Bovine; Tamoxifen; Thiocyanates; Time Factors | 1982 |
Estrogen receptors in human breast cancer. II. Correlation between the histochemical method and biochemical assay.
Topics: Adult; Aged; Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Epithelium; Estradiol; Fluorescein-5-isothiocyanate; Fluoresceins; Histocytochemistry; Humans; Middle Aged; Receptors, Estrogen; Serum Albumin, Bovine; Thiocyanates | 1982 |
Estrogen receptors in carcinoma of the breast. A comparison of the dextran-coated charcoal, immunofluorescent, and immunoperoxidase technics.
Topics: Adult; Aged; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Middle Aged; Prospective Studies; Receptors, Estrogen; Staining and Labeling; Thiocyanates | 1983 |
Incorporation of alphafetoprotein by the MCF-7 human breast cancer cell line.
Topics: Albumins; alpha-Fetoproteins; Animals; Autoradiography; Breast Neoplasms; Cell Line; Chickens; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Immunoenzyme Techniques; Mice; Serum Albumin; Swine; Thiocyanates | 1984 |
The binding of fluorescent-labelled concanavalin A to human breast tissue--a marker of differentiation.
Topics: Breast; Breast Neoplasms; Concanavalin A; Female; Fixatives; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Hyperplasia; Lymphatic Metastasis; Microscopy, Fluorescence; Neoplasm Staging; Thiocyanates | 1983 |
Fluorescent cytochemical oestrogen receptor assay: is it valid in breast cancer?
Topics: Adsorption; Adult; Aged; Breast Neoplasms; Charcoal; Estradiol; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Histocytochemistry; Humans; Methods; Microscopy, Fluorescence; Middle Aged; Receptors, Estrogen; Serum Albumin, Bovine; Thiocyanates | 1983 |
Lectin-binding affinities of human breast tumors.
Topics: Breast; Breast Neoplasms; Female; Fibrocystic Breast Disease; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Lectins; Microscopy, Fluorescence; Receptors, Mitogen; Thiocyanates | 1983 |
Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods.
Topics: Antibodies; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Histocytochemistry; Hormones; Humans; Receptors, Estrogen; Serum Albumin, Bovine; Thiosemicarbazones | 1984 |
Fluorescein-concanavalin A conjugates distinguish between normal and malignant human cells: a preliminary report.
Topics: Breast Neoplasms; Concanavalin A; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin; Skin Neoplasms; Thiocyanates | 1981 |
Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.
Topics: Antibodies, Monoclonal; Breast Neoplasms; DNA, Neoplasm; Epithelium; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Follow-Up Studies; Humans; Keratins; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Receptors, Estrogen; Recurrence; S Phase | 1994 |
Detection of bone marrow breast carcinoma metastasis using multiparameter flow cytometry.
Topics: Antibodies, Monoclonal; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Glycophorins; Humans; Keratins; Leukocyte Common Antigens; Neoplasm Metastasis; Phycoerythrin; Tumor Cells, Cultured | 1993 |
Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Lung Neoplasms; Mesothelioma; Tumor Cells, Cultured | 1993 |
[Development of a technique for isolation of intact tumor cells from fresh breast or ovarian cancer tissue. Use in analysis of tumor-associated proteolytic factors].
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Separation; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Ovarian Neoplasms; Peptide Hydrolases; Ploidies; Tumor Cells, Cultured | 1993 |
Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells.
Topics: Blotting, Northern; Breast Neoplasms; Cell Division; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Fluorescein-5-isothiocyanate; Genes, fos; Humans; Neoplasms, Hormone-Dependent; Phosphorylation; Proto-Oncogene Mas; RNA, Messenger; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 1994 |
Flow cytometric analysis of DNA and nuclear protein in paraffin-embedded tissue.
Topics: Aneuploidy; Breast Neoplasms; Carcinoma; Cell Separation; Colonic Neoplasms; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Kidney Neoplasms; Nuclear Proteins; Paraffin Embedding; Pepsin A; Propidium | 1993 |
Use of a multiparametric panel to target subpopulations in a heterogeneous solid tumor model for improved analytical accuracy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Division; Cell Survival; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Indoles; Keratins; Lasers; Leukocytes, Mononuclear; Optics and Photonics; Ploidies; Population; Proliferating Cell Nuclear Antigen; Serine Proteinase Inhibitors; Tubulin; Tumor Cells, Cultured | 1995 |
Labelling of breast carcinoma, thyroid carcinoma and melanoma with manno- and galacto-specific lectins from marine invertebrates.
Topics: Animals; Breast Neoplasms; Fluorescein-5-isothiocyanate; Galactose; Galectins; Hemagglutinins; Humans; Lectins; Lymphatic Metastasis; Mannose; Mannose-Binding Lectins; Melanoma; Porifera; Skin Neoplasms; Substrate Specificity; Thyroid Neoplasms | 1996 |
Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization.
Topics: Adult; Aged; Breast Neoplasms; Chromosome Aberrations; Chromosome Mapping; DNA, Neoplasm; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Lymphatic Metastasis; Metaphase; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nucleic Acid Hybridization | 1997 |
Analysis of the interaction of procathepsin D activation peptide with breast cancer cells.
Topics: Animals; Antibodies; Breast Neoplasms; Cathepsin D; Cell Line; Enzyme Activation; Enzyme Precursors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Receptor, IGF Type 2; Receptors, Growth Factor | 1997 |
Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal-deoxynucleotidyl-transferase-mediated dUTP-FITC nick end labelling (TUNEL
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Deoxyuracil Nucleotides; DNA Nucleotidylexotransferase; Fluorescein-5-isothiocyanate; Genetic Techniques; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Tumor Suppressor Protein p53 | 1997 |
Tamoxifen in early breast cancer.
Topics: Antineoplastic Agents, Hormonal; Biomarkers; Breast Neoplasms; CD36 Antigens; Estrogen Antagonists; Fatty Liver; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Tamoxifen | 1998 |
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antimetabolites; Breast Neoplasms; Bromodeoxyuridine; CHO Cells; Coloring Agents; Cricetinae; DNA, Neoplasm; Energy Transfer; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; G1 Phase; G2 Phase; Humans; Propidium | 1999 |
Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro.
Topics: Breast Neoplasms; Cell Movement; Cell Separation; Cell Surface Extensions; Extracellular Matrix; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gelatin; Humans; Neoplasm Invasiveness; Phagocytosis; Tumor Cells, Cultured | 2001 |
Multiparameter analysis of human epithelial tumor cell lines by laser scanning cytometry.
Topics: Breast Neoplasms; Carbocyanines; Carcinoma; Cell Nucleus; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluoroimmunoassay; Humans; Microscopy, Confocal; Organic Chemicals; Phycoerythrin; Sensitivity and Specificity; Tissue Fixation; Tumor Cells, Cultured | 2000 |
Flow cytometric DNA analysis using cytokeratin labeling for identification of tumor cells in carcinomas of the breast and the female genital tract.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; DNA; Epithelial Cells; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Genital Neoplasms, Female; Humans; Keratins; Ploidies; Prospective Studies; S Phase; Sensitivity and Specificity | 2001 |
Different lectin-binding patterns in primary breast cancers and their metastases.
Topics: Breast Neoplasms; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Glycoconjugates; Humans; Lectins; Microscopy, Fluorescence; Neoplasm Metastasis; Staining and Labeling; Thiocyanates | 1990 |
The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.
Topics: Antigens, Surface; Breast Neoplasms; Esophageal Neoplasms; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Lymphocytes; Stomach Neoplasms; Suppressor Factors, Immunologic; Thiocyanates; Wheat Germ Agglutinins | 1990 |
Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Histocytochemistry; Humans; Immunoassay; Lectins; Lymphocytes; Peanut Agglutinin; Receptors, Estrogen; Receptors, Mitogen; Sex Chromatin; Thiocyanates | 1986 |
Influence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Dexamethasone; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Mitogen; Steroids; Thiocyanates; Tretinoin | 1986 |
Lectin-binding sites in Paget's disease.
Topics: Apocrine Glands; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Eccrine Glands; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Paget Disease, Extramammary; Paget's Disease, Mammary; Receptors, Mitogen; Skin; Thiocyanates | 1985 |
Comparative study between histochemical and biochemical estimation of estrogen receptors in tumors.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Centrifugation, Density Gradient; Cytosol; Estradiol; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Histiocytoma, Benign Fibrous; Histocytochemistry; Humans; Receptors, Estrogen; Serum Albumin, Bovine; Spectrometry, Fluorescence | 1985 |
Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems.
Topics: Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Line; Cell Membrane; Estradiol; Estrogens, Conjugated (USP); Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Kinetics; Neuraminidase; Phospholipases A; Phospholipases A2; Receptors, Estradiol; Receptors, Estrogen; Serum Albumin, Bovine; Spectrometry, Fluorescence; Thiocyanates; Trypsin | 1986 |
Lectin binding in human breast cancer: clinical and pathologic correlations with fluorescein-conjugated peanut, wheat germ and concanavalin A binding.
Topics: Breast Neoplasms; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Lectins; Middle Aged; Neoplasm Staging; Peanut Agglutinin; Receptors, Estrogen; Statistics as Topic; Wheat Germ Agglutinins | 1988 |
Measurement of ligand binding, E-BSA-FITC.
Topics: Breast Neoplasms; Estradiol; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Serum Albumin, Bovine | 1986 |
The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Topics: Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Interphase; Lymphocytes; Monocytes; Purpura, Thrombocytopenic; Thiocyanates | 1985 |
Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions.
Topics: Binding, Competitive; Breast Neoplasms; Cell Line; Diethylstilbestrol; Estradiol; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Histocytochemistry; Humans; Kinetics; Receptors, Estrogen; Serum Albumin, Bovine | 1985 |